Ploidy as a predictive biomarker for gemcitabine sensitivity in triple-negative breast cancers

被引：0
|
作者：
Tagal, Vural
Cole, Jackson P.
Miroshnychenko, Daria
Marusyk, Andriy
Andor, Noemi
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-LB175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] TTK: A novel target for radiosensitization in triple-negative breast cancers
    Chandler, Benjamin C.
    Moubadder, Leah
    Ritter, Cassie
    Niknafs, Yashar
    Olsen, Eric
    Cameron, Meleah
    Liu, Meilan
    Wilder-Romans, Kari
    Nyati, Shyam
    Brown, Powel
    Chinnaiyan, Arul
    Speers, Corey
    CANCER RESEARCH, 2018, 78 (13)
  • [42] Targeting a cell state common to triple-negative breast cancers
    Muellner, Markus K.
    Mair, Barbara
    Ibrahim, Yasir
    Kerzendorfer, Claudia
    Lechtermann, Hannelore
    Trefzer, Claudia
    Klepsch, Freya
    Mueller, Andre C.
    Leitner, Ernestine
    Macho-Maschler, Sabine
    Superti-Furga, Giulio
    Bennett, Keiryn L.
    Baselga, Jose
    Rix, Uwe
    Kubicek, Stefan
    Colinge, Jacques
    Serra, Violeta
    Nijman, Sebastian M. B.
    MOLECULAR SYSTEMS BIOLOGY, 2015, 11 (02)
  • [43] Pathway Analysis of Primary Human Triple-Negative Breast Cancers
    Ossovskaya, V.
    Xu, Q.
    Lituev, A.
    Potapova, O.
    Monforte, J.
    Daraselia, N.
    CANCER RESEARCH, 2010, 70
  • [44] GATA3 expression in triple-negative breast cancers
    Byrne, David J.
    Deb, Siddhartha
    Takano, Elena A.
    Fox, Stephen B.
    HISTOPATHOLOGY, 2017, 71 (01) : 63 - 71
  • [45] Imputing a more targeted therapy for triple-negative breast cancers
    Gruener, Robert F.
    Greene, Geoffrey L.
    Huang, R. Stephanie
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 25 - 26
  • [46] Triple-Negative Breast Cancers: Unique Clinical Presentations and Outcomes
    Yee, Julie
    Dueck, Amylou
    Stucky, Chee-Chee
    Gray, Richard
    Wasif, Nabil
    Northfelt, Donald
    McCullough, Ann
    Pockaj, Barbara
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : S156 - S156
  • [47] Efavirenz as a potential drug for the treatment of triple-negative breast cancers
    Chiou, P-T
    Ohms, S.
    Board, P. G.
    Dahlstrom, J. E.
    Rangasamy, D.
    Casarotto, M. G.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (02): : 353 - 363
  • [48] What Is the Difference Between Triple-Negative and Basal Breast Cancers?
    Seal, Melanie D.
    Chia, Stephen K.
    CANCER JOURNAL, 2010, 16 (01): : 12 - 16
  • [49] Classification of triple-negative breast cancers based on Immunogenomic profiling
    Yin He
    Zehang Jiang
    Cai Chen
    Xiaosheng Wang
    Journal of Experimental & Clinical Cancer Research, 37
  • [50] The role of tenascin-C in triple-negative breast cancers
    Ivanov, A.
    Popova, O.
    Bogomazova, S.
    Danilova, T.
    VIRCHOWS ARCHIV, 2016, 469 : S52 - S52
12345